Prospective Pilot Study ANDPrecise
ANDPrecise
AND Precise! : Axillary Lymph Node Dissection and No Drain With the PRECISE Instrument
1 other identifier
interventional
20
1 country
1
Brief Summary
This study aims at providing first evidence that axillary clearance by using an operation technique including the precise LigaSure instrument and closure of dead space of the axilla will result in an operation were a drain is not necessary and the need for seroma evacuation after surgery is very limited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 breast-cancer
Started Jun 2012
Typical duration for phase_3 breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 27, 2014
CompletedFirst Posted
Study publicly available on registry
November 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedNovember 17, 2014
October 1, 2014
5 years
October 27, 2014
November 12, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Number of seroma evacuations per patient
within 3 months after surgery
Secondary Outcomes (2)
Number of wound infections per patient
within 3 months after surgery
Number of hematomas per patient
within 3 months after surgery
Study Arms (1)
LigaSure Precise instrument
EXPERIMENTALALND with use of LigaSure Precise instrument, closure of dead space, omission of a postoperative drain.
Interventions
LigaSure Precise instrument is used during Axillary Lymph Node Dissection Technique: Dead space closure Technique: Omission of postoperative drain
Eligibility Criteria
You may qualify if:
- Indications for axillary clearance can be a tumor positive sentinel node or tumor positive lymph nodes proven by ultrasound or fine needle aspiration cytology.
- For this pilot, only patients undergoing breast conserving surgery are eligible.
- Axillary clearance can be performed after previous sentinel node procedure, at the same operation, and after neo-adjuvant chemo therapy, and as secondary procedure in case of axillary relapse after previous treatment for breast cancer.
You may not qualify if:
- Patients undergoing a modified radical mastectomy including an axillary clearance.
- Preoperative preexisting seroma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Amsterdam, 1066CX, Netherlands
Related Publications (5)
van Bemmel AJ, van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol. 2011 Oct;37(10):829-35. doi: 10.1016/j.ejso.2011.04.012. Epub 2011 Aug 17.
PMID: 21849243BACKGROUNDBaas-Vrancken Peeters MJ, Kluit AB, Merkus JW, Breslau PJ. Short versus long-term postoperative drainage of the axilla after axillary lymph node dissection. A prospective randomized study. Breast Cancer Res Treat. 2005 Oct;93(3):271-5. doi: 10.1007/s10549-005-5348-7.
PMID: 16172795BACKGROUNDClasse JM, Berchery D, Campion L, Pioud R, Dravet F, Robard S. Randomized clinical trial comparing axillary padding with closed suction drainage for the axillary wound after lymphadenectomy for breast cancer. Br J Surg. 2006 Jul;93(7):820-4. doi: 10.1002/bjs.5433.
PMID: 16775817BACKGROUNDOstapoff KT, Euhus D, Xie XJ, Rao M, Moldrem A, Rao R. Axillary lymph node dissection for breast cancer utilizing Harmonic Focus(R). World J Surg Oncol. 2011 Aug 15;9:90. doi: 10.1186/1477-7819-9-90.
PMID: 21843361BACKGROUNDGong Y, Xu J, Shao J, Cheng H, Wu X, Zhao D, Xiong B. Prevention of seroma formation after mastectomy and axillary dissection by lymph vessel ligation and dead space closure: a randomized trial. Am J Surg. 2010 Sep;200(3):352-6. doi: 10.1016/j.amjsurg.2009.10.013. Epub 2010 Apr 20.
PMID: 20409509BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emiel Rutgers, MD, PhD
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2014
First Posted
November 17, 2014
Study Start
June 1, 2012
Primary Completion
June 1, 2017
Study Completion
June 1, 2018
Last Updated
November 17, 2014
Record last verified: 2014-10